Hear the people of NeuroSense discuss the science behind our drug, and present pre-clinical and preliminary clinical results.


Opening: 0:21

Introduction to NeuroSense’s Story: 3:40

PrimeC Mechanism of Action: 9:02

Pre-Clinical Results: 14:45

Pre-Clinical results summary: 24:56

PrimeC Unique Formulation: 26:57

Clinical Study NST002 Interim Top-Line Results: 29:14

Next Steps: 37:32

Q&A: 38:29


Two of the women behind NeuroSense Therapeutics share their life stories and discuss the special value of women in the scientific world.


Read about the promising preliminary results of our clinical trial in ALS patients.